Cargando…
Immune evader cancer stem cells direct the perspective approaches to cancer immunotherapy
Exploration of tumor immunity leads to the development of immune checkpoint inhibitors and cell-based immunotherapies which improve the clinical outcomes in several tumor types. However, the poor clinical efficacy of these treatments observed for other tumors could be attributed to the inherent comp...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994338/ https://www.ncbi.nlm.nih.gov/pubmed/35395787 http://dx.doi.org/10.1186/s13287-022-02829-9 |